
Global Metagenomics in Healthcare Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Metagenomics in Healthcare market size will reach US$ million by 2031.
Metagenomics is the study of genetic material recovered directly from environmental samples.
United States market for Metagenomics in Healthcare is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Metagenomics in Healthcare is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Metagenomics in Healthcare is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Metagenomics in Healthcare players cover Illumina, QIAGEN, PerkinElmer, Thermo Fisher Scientific, Oxford Nanopore Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Metagenomics in Healthcare Industry Forecast” looks at past sales and reviews total world Metagenomics in Healthcare sales in 2024, providing a comprehensive analysis by region and market sector of projected Metagenomics in Healthcare sales for 2025 through 2031. With Metagenomics in Healthcare sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metagenomics in Healthcare industry.
This Insight Report provides a comprehensive analysis of the global Metagenomics in Healthcare landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Metagenomics in Healthcare portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metagenomics in Healthcare market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metagenomics in Healthcare and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metagenomics in Healthcare.
This report presents a comprehensive overview, market shares, and growth opportunities of Metagenomics in Healthcare market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sample Extraction Kits
Metagenomics Kits
Segmentation by Application:
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Please note: The report will take approximately 2 business days to prepare and deliver.
Metagenomics is the study of genetic material recovered directly from environmental samples.
United States market for Metagenomics in Healthcare is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Metagenomics in Healthcare is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Metagenomics in Healthcare is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Metagenomics in Healthcare players cover Illumina, QIAGEN, PerkinElmer, Thermo Fisher Scientific, Oxford Nanopore Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Metagenomics in Healthcare Industry Forecast” looks at past sales and reviews total world Metagenomics in Healthcare sales in 2024, providing a comprehensive analysis by region and market sector of projected Metagenomics in Healthcare sales for 2025 through 2031. With Metagenomics in Healthcare sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metagenomics in Healthcare industry.
This Insight Report provides a comprehensive analysis of the global Metagenomics in Healthcare landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Metagenomics in Healthcare portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Metagenomics in Healthcare market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metagenomics in Healthcare and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metagenomics in Healthcare.
This report presents a comprehensive overview, market shares, and growth opportunities of Metagenomics in Healthcare market by product type, application, key players and key regions and countries.
Segmentation by Type:
Sample Extraction Kits
Metagenomics Kits
Segmentation by Application:
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
79 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Metagenomics in Healthcare Market Size by Player
- 4 Metagenomics in Healthcare by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Metagenomics in Healthcare Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.